Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite
Lancet Oncol
.
2023 May;24(5):431-432.
doi: 10.1016/S1470-2045(23)00141-9.
Epub 2023 Mar 23.
Authors
Russell C Cattley
1
,
Hans Kromhout
1
,
Meng Sun
1
,
Erik J Tokar
1
,
Mohamed A-E Abdallah
1
,
Alison K Bauer
1
,
Kendra R Broadwater
1
,
Laura Campo
1
,
Emanuela Corsini
1
,
Keith A Houck
1
,
Gaku Ichihara
1
,
Michiharu Matsumoto
1
,
Simone Morais
1
,
Jaroslav Mráz
1
,
Tetsuo Nomiyama
1
,
Kristen Ryan
1
,
Huizhong Shen
1
,
Takeshi Toyoda
1
,
Kirsi Vähäkangas
1
,
Marianna G Yakubovskaya
1
,
Il Je Yu
1
,
Nathan L DeBono
1
,
Aline de Conti
1
,
Fatiha El Ghissassi
1
,
Federica Madia
1
,
Heidi Mattock
1
,
Elisa Pasqual
1
,
Eero Suonio
1
,
Roland Wedekind
1
,
Lamia Benbrahim-Tallaa
1
,
Mary K Schubauer-Berigan
1
Affiliation
1
International Agency for Research on Cancer, Lyon, France.
PMID:
36966774
DOI:
10.1016/S1470-2045(23)00141-9
No abstract available
Publication types
News
MeSH terms
Anthracenes
Humans
Organophosphonates*
Substances
dimethyl hydrogen phosphite
2-bromopropane
butyl methacrylate
Organophosphonates
Anthracenes
Grants and funding
001/WHO_/World Health Organization/International
R01 CA033193/CA/NCI NIH HHS/United States
U01 CA033193/CA/NCI NIH HHS/United States